|Bid||20.00 x 0|
|Ask||21.00 x 0|
|Day's range||20.17 - 20.80|
|52-week range||12.62 - 38.40|
|Beta (5Y monthly)||0.23|
|PE ratio (TTM)||N/A|
|Earnings date||21 Apr 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||120.00|
Avacta Group announces it has signed a collaboration and license agreement to develop Affimer® proteins to be used by AffyXell Therapeutics
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
As every investor would know, not every swing hits the sweet spot. But you have a problem if you face massive losses...